About 40% of at-risk patients with COPD did not receive maintenance therapy despite having frequent or severe exacerbations.

The late-stage miss shakes analyst confidence in Regeneron’s clinical execution, according to BMO Capital Markets, also ...

Hospital Authority says patient, who had history of chronic obstructive pulmonary disease and high cholesterol, died ...

GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk: London, UK Tuesday, May 19, 2026, 12:00 Hrs [IST] GSK plc announced tha ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of the Viz ...

If you have chronic obstructive pulmonary disease (COPD)—an umbrella term for several lung diseases, including emphysema, ...

Chronic obstructive pulmonary disease, or COPD, is one of the world’s leading causes of death, responsible for 3.5 million ...

Guiding people on how to correctly use inhaled medications via a phone-based program can help improve technique, according to ...

Lupin received US FDA tentative approval for Revefenacin Inhalation Solution (175 mcg/3 mL), bioequivalent to Yupelri, ...

The UK's coastal ambient air quality, often perceived as inherently healthpromoting, contrasts with the poor health outcomes ...

Anti-inflammatory inhalers help control asthma and COPD by reducing airway inflammation. It improves breathing, prevent flare ...

When my dad was diagnosed with chronic obstructive pulmonary disease (COPD) in 2004, I did what many caregivers do: I started ...